---
title: "Molecular Pathway Linked to Statin-Induced Muscle Pain Identified by McMaster Researchers"
url: https://projectchintan.com/article/molecular-pathway-linked-to-statin-induced-muscle-pain-identified-by-mcmaster-re-j9mak
publisher: Project Chintan
author: Project Chintan Newsroom
published: 2026-08-01T12:09:55.000Z
modified: 2026-08-01T16:01:34.441Z
language: en-IN
---

# Molecular Pathway Linked to Statin-Induced Muscle Pain Identified by McMaster Researchers

Scientists have uncovered a biological link between statin use and muscle damage that operates independently of cholesterol reduction. This discovery could lead to new treatments that eliminate side effects while preserving heart benefits.

## Key takeaways

- McMaster University researchers found that statins trigger an immune response in muscle cells by disrupting energy metabolism.
- Between 7% and 29% of patients experience muscle pain or weakness, often leading them to discontinue life-saving statin therapy.
- The mechanism causing muscle damage is entirely separate from the process that lowers cholesterol levels.
- Blocking the identified immune pathway in mouse models prevented muscle tissue damage without reducing the drug's efficacy.

A breakthrough study from McMaster University has identified a specific biological mechanism that triggers muscle pain and weakness in statin users. Published in Science Advances, the research explains how these cholesterol-lowering drugs interact with muscle cell metabolism and the immune system, providing a potential roadmap for mitigating side effects that currently affect millions of patients.

## Metabolic Disruption and Immune Response

Statins are frequently prescribed to prevent strokes and heart attacks, yet an estimated 7% to 29% of users experience debilitating muscle symptoms. Led by first authors Nazli Robin and Nicole Barra of the Schertzer Lab, the research team discovered that statins interfere with energy production within muscle cells. This metabolic disturbance triggers an internal immune response, causing tissue damage that manifests as pain or exercise intolerance.

Jonathan Schertzer, a professor at McMaster’s Department of Biochemistry and Biomedical Sciences, noted that this immune activation is distinct from the process that lowers cholesterol. Experiments involving mouse models and muscle cells demonstrated that blocking this specific immune pathway prevented significant damage without impacting the drug's cardiovascular efficacy.

## Path to Improved Patient Compliance

The findings offer a new perspective on how inflammation contributes to medication side effects. By isolating the mechanism responsible for muscle damage, scientists may be able to develop targeted therapies to protect muscle tissue while maintaining the life-saving benefits of statins.
- Statins act as a double-edged sword, effectively reducing death risk while causing compliance-breaking muscle fatigue for nearly a third of patients.
- The study reveals that muscle cells activate their own immune response when their energy processing is disrupted by the medication.
- International collaboration spanned institutions in France, Australia, and Canada, including the Centre International de Recherche en Infectiologie and the University of Melbourne.

While further clinical investigation is required before these findings translate into new prescriptions, the identified pathway provides concrete targets for future drug development. The work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC).

Source: ScienceDaily

---
Canonical: https://projectchintan.com/article/molecular-pathway-linked-to-statin-induced-muscle-pain-identified-by-mcmaster-re-j9mak
Reported from: ScienceDaily